axicabtagene ciloleucel
gilead sciences,daiichi sankyo
['axi-cel']
check out the longitudinal pro data. physical function initially worse in axi-cel arm, then significantly improves. important in patient counseling. also, soc scores never exceeded baseline. #majorprosasco #tcellrx #asco22 
Hematology/oncology fellow. #lymsm & #mmsm outcomes researcher. Physician-publisher & founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????